Exact Sciences Corporation revised revenue guidance for the full year of 2022. The company anticipates revenue of $2,025 million -$2,042 million during 2022. Revenue guidance has been raised from the previously expected range of $1,980 million -$2,022 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.85 USD | +0.10% | -3.46% | -20.45% |
Apr. 17 | Exact Sciences Corporation announced that it has received $266.75 million in funding | CI |
Apr. 15 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 377M | |
+13.32% | 332M |
- Stock Market
- Equities
- EXAS Stock
- News Exact Sciences Corporation
- Exact Sciences Corporation Revises Revenue Guidance for the Full Year of 2022